![]() |
HERmark Presents Assay Results In Metastatic Breast Cancer
Monogram Biosciences presented the results of a study detailing the HERmark Assay's ability to identify metastatic breast cancer patients who are most likely to respond to Herceptin
full article: http://www.emaxhealth.com/98/19118.html |
| All times are GMT -7. The time now is 08:43 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021